INS and cancer: Some studies have suggested that decreased muscle function in cancer patients is the result of local muscle inflammation, and that increased inflammatory cytokines can also lead to insulin resistance and muscle depletion by activating the ubiquitin-proteasome proteolytic pathway (24, 25).